Morphine Sulfate Extended-Release Tablets 30 mg recall: Impurity Out of Spec
Morphine Sulfate Extended-Release Tablets 30 mg, 100-count bottles, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-186-01.
Why was Morphine Sulfate Extended-Release Tablets 30 mg recalled?
Failed Impurities/Degradation Specification
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot# FG13996, Exp 09/30/2025
- Product
- Morphine Sulfate Extended-Release Tablets 30 mg, 100-count bottles, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-186-01.
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
- Quantity
- 532 100-count bottles
- Distribution
- Nationwide in the USA
- Recall date
- November 13, 2024
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)